Philip Morris
Fields
- Type
- COMP, COMPUTER PRINTOUT
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Attachment
- 2048252199/2048252525
- 2048252502/2048252505
- Site
- N403
- Request
- Stmn/R1-048
- Recipient
- Mcalpin, L.
- Document File
- 2048252198/2048252525/Bero Barnes (Ciar)
- Named Person
- Stolberg, S.
- Litigation
- Stmn/Produced
- Master ID
- 2048252379/2524
Related Documents:- 2048252379 Requested Papers
- 2048252380
- 2048252381-2386 Evaluating the Quality of Articles Published in Journal Supplements Compared with the Quality of Those Published in the Parent Journal
- 2048252387 Preventing Alcohol and Substance Abuse in Minority Youth Recent Results From Asap Training and Demonstration Programs. Prevention Works: Trends in Drug Abuse Education 760000 - 900000. Long Term Prevention of Tobacco Use Among Junior High School Students Through Classroom and Telephone Interventions. Misuse of the Scientific Literature by the Tobacco Industry.
- 2048252388-2391 Appendix Coding Definitions for Article Content
- 2048252392-2402 Tobacco Industry Response to A Risk Assessment of Environmental Tobacco Smoke
- 2048252403 Quit and Win Wales: An Evaluation of the 900000 Pilot Content
- 2048252404-2406 Inappropriate and Appropriate Selection of 'peers' in Grant Review. Public Bias and Public Policy
- 2048252407-2414 Sponsored Symposia on Environmental Tobacco Smoke
- 2048252415-2418 Publication Bias and Public Health Policy on Environmental Tobacco Smoke
- 2048252419
- 2048252420-2421 Taking Money From the Devil
- 2048252422
- 2048252423-2429 the Publication of Sponsored Symposiums in Medical Journals
- 2048252430-2431 Tobacco Industry Funding of Biomedical Research
- 2048252432
- 2048252433-2438 Ethical Issues Relating to the Conduct and Interpretation of Epidemiologic Research in Private Industry
- 2048252439
- 2048252440-2445 Independent Investigators and for-Profit Companies Guidelines for Biomedical Scientists Considering Funding by Industry
- 2048252446
- 2048252447-2450 Source of Funding and Outcome of Clinical Trials
- 2048252451
- 2048252452-2456 Sounding Board Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies
- 2048252457
- 2048252458-2465 Uniform Requirements for Manuscripts Submitted to Biomedical Journals
- 2048252466
- 2048252467 Editorial Conflict of Interest Policy
- 2048252468
- 2048252469-2471 New Requirements for Authors: Signed Statements of Authorship Responsibility and Financial Disclosure
- 2048252472
- 2048252473-2475 Commentary Conflict of Interest and Scientific Publicati
- 2048252476
- 2048252477-2479 Dealing with Conflicts of Interest
- 2048252480
- 2048252481-2482 New 'information for Authors' - and Readers
- 2048252483-2491 A Study of Manufacturer - Supported Trials of Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Arthritis Reporting and Documentation of Efficacy and Toxicity
- 2048252492
- 2048252493-2497 Sounding Board Physicians' Conflicts of Interest the Limitations of Disclosure
- 2048252498
- 2048252499-2501 Commentary Conflict of Interest the New Mccarthyism in Science
- 2048252503-2505 Researchers Try to Separate Smoking Fact From Fiction
- 2048252506-2507
- 2048252508-2513 Influence of Design Characteristics on the Outcome of Retrospective Cohort Studies
- 2048252514
- 2048252515-2519 Conflict of Interest Dilemmas in Biomedical Research
- 2048252520
- 2048252521-2524 When Researchers Accept Funding From the Tobacco Industry, Do Ethics Go Up in Smoke? the Research Game.
- Named Organization
- Cua
- Los Angeles Times
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- tis65e00
Document Images
:204$25 2502
Order Date 6 Tiae 29-NOV-95 @ 15 :01 Meeds Bys To Location: GUA Staffer; 1
CEIi llumber: NEWSMICRO I
JoUmal/Dook 9itle: LOS ANGELES TIT"1ES
MAY 28 1994
I
iLI1
I
0
I
Volmve; I:sue: ISSII/ISBII:
DATE: 1994 MAY
PAGES: Al
Articlt Yitle: RESEARCHERS TRY TO SEPARATE SMOKING FACT FROM FICTION
Author: STOLBERG, S
Page Count
i
Reason Not Filled
[
1
Bote: FAA TO: B41-214-3055 AT7M: IOBEEIt ?ICALPIN
Nl
R
t
CUA I
uner
a
e:
1
; Client Order Hu4.: 8817
~ . Clieqt Sequence 1:
~
. Client Sequence 2:
SDS
FNHN
Ord 5383070
A
Sl
ot 1167U
~ .
~
3
~
~
~
~
~
r
i
